Treatment Options Post Exposure to COVID-19
Introductory content goes here…
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Mauris placerat ullamcorper sem eu sodales. Praesent suscipit mauris nec augue bibendum, ut consequat massa sodales. Proin et lacus enim. Vivamus vulputate luctus ultrices. Quisque consequat porttitor fringilla. Mauris vitae nulla porttitor, gravida diam et, egestas mauris. Mauris convallis metus at urna rutrum, eget hendrerit metus porttitor. Maecenas posuere lorem rhoncus nisi eleifend mollis.
Web Tip: This has the potential to change everything and give us freedom like that already enjoyed by those vaccinated who have a normal immune system.
CLL Society’s COVID-19 Update for the Week of November 28th, 2022
CLL Society’s COVID-19 Update for the Week of November 28th, 2022: Here is your weekly summary of what has been happening this past week in the United States. Keep in mind, data is always going to be delayed/underreported when there is a holiday weekend due to government offices being closed. But we are still going to provide the latest information available to us.
CLL Society’s COVID-19 Update for the Week of November 21st, 2022
CLL Society’s COVID-19 Update for the Week of November 21st, 2022: Here is your weekly summary of what has been happening this past week in the United States. The variant picture continues to shift rapidly. Read more on this below.
ASH 2021: Antibody and T-Cell Responses to Covid-19 mRNA Vaccines in Patients with B-Cell Lymphomas and Chronic Lymphocytic Leukemia (CLL)
Compared to the earlier study, this one used a larger and broader cohort of patients. They included patients with diagnoses of CLL, and related B-cell lymphomas, namely marginal zone lymphoma, diffuse large B-cell lymphoma, follicular lymphoma, mantle cell lymphoma, and Waldenstrom’s macroglobulinemia.
ASH 2021: Humoral (Antibody) and Cellular Immunogenicity of COVID-19 Vaccinations in Patients with CLL
In the past three years since SARS-CoV-2 has been active, patients with compromised or suppressed immune systems have worried, wondered, and waited for an answer to the one big question -will treatment or immunizations work for me?
CLL Society’s COVID-19 Update for the Week of November 14th, 2022
CLL Society’s COVID-19 Update for the Week of November 14th, 2022: Here is your weekly summary of what has been happening this past week in the United States. The variant picture continues to shift rapidly. Read more on this below.
Many Patients with Weak Immune Systems Don’t Realize Their COVID-19 Medicine Isn’t as Effective as It Used to Be
CNN interviewed CLL Society’s Dr. Brian Koffman and Robyn Brumble, RN, among others, to gain perspective on the significance of the diminishing susceptibility of the emerging SARS-CoV-2 Variants of Concern (VOC) to Evusheld, the only Pre-Exposure Prophylaxis (PrEP) for the immunocompromised; including all those with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL).
RECENT NEWS
When appropriate, the CLL Society will be posting updates and background information on the present Coronavirus pandemic focusing on reliable primary sources of information and avoiding most of the news that is not directly from reliable medical experts or government and world health agencies.
